CHE
Price
$534.22
Change
-$14.42 (-2.63%)
Updated
Nov 5, 04:59 PM (EDT)
Capitalization
7.17B
111 days until earnings call
Intraday BUY SELL Signals
UHS
Price
$198.59
Change
+$2.13 (+1.08%)
Updated
Nov 5 closing price
Capitalization
11.58B
117 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CHE vs UHS

CHE vs UHS Comparison Chart in %
View a ticker or compare two or three
VS
CHE vs. UHS commentary
Nov 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHE is a Buy and UHS is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CHE with price predictions
Nov 04, 2026

Momentum Indicator for CHE turns positive, indicating new upward trend

CHE saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 55 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 60%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CHE just turned positive on October 14, 2026. Looking at past instances where CHE's MACD turned positive, the stock continued to rise in 27 of 51 cases over the following month. The odds of a continued upward trend are 53%.

CHE moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CHE crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in 159 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.

The Aroon Indicator entered an Uptrend today. In 76 of 200 cases where CHE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 38%.

Bearish Trend Analysis

The 10-day RSI Indicator for CHE moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 28 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 69 cases where CHE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 48%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

CHE broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. CHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.634) is normal, around the industry mean (204.059). P/E Ratio (27.584) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (1.876) is also within normal values, averaging (2.498). Dividend Yield (0.005) settles around the average of (0.091) among similar stocks. P/S Ratio (2.714) is also within normal values, averaging (2.688).

A.I.Advisor
a Summary for UHS with price predictions
Nov 04, 2026

UHS sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for UHS moved above the 200-day moving average on October 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 53 cases where UHS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on UHS as a result. In 64 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for UHS just turned positive on November 04, 2026. Looking at past instances where UHS's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.

UHS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where UHS advanced for three days, in 236 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

The Aroon Indicator entered an Uptrend today. In 199 of 298 cases where UHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Bearish Trend Analysis

The 10-day RSI Indicator for UHS moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 25 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

UHS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. UHS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.

The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.541) is normal, around the industry mean (204.059). P/E Ratio (7.931) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (1.197) is also within normal values, averaging (2.498). Dividend Yield (0.004) settles around the average of (0.091) among similar stocks. P/S Ratio (0.621) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
CHE vs UHS: Fundamental Ratings
CHE
UHS
OUTLOOK RATING
1..100
2380
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
6759
SMR RATING
1..100
3645
PRICE GROWTH RATING
1..100
4355
P/E GROWTH RATING
1..100
2881
SEASONALITY SCORE
1..100
5036

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UHS's Valuation (60) in the Hospital Or Nursing Management industry is in the same range as CHE (78) in the Medical Or Nursing Services industry. This means that UHS’s stock grew similarly to CHE’s over the last 12 months.

UHS's Profit vs Risk Rating (59) in the Hospital Or Nursing Management industry is in the same range as CHE (67) in the Medical Or Nursing Services industry. This means that UHS’s stock grew similarly to CHE’s over the last 12 months.

CHE's SMR Rating (36) in the Medical Or Nursing Services industry is in the same range as UHS (45) in the Hospital Or Nursing Management industry. This means that CHE’s stock grew similarly to UHS’s over the last 12 months.

CHE's Price Growth Rating (43) in the Medical Or Nursing Services industry is in the same range as UHS (55) in the Hospital Or Nursing Management industry. This means that CHE’s stock grew similarly to UHS’s over the last 12 months.

CHE's P/E Growth Rating (28) in the Medical Or Nursing Services industry is somewhat better than the same rating for UHS (81) in the Hospital Or Nursing Management industry. This means that CHE’s stock grew somewhat faster than UHS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHEUHS
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 8 days ago
49%
Bullish Trend 22 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
49%
Bearish Trend 9 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
50%
Aroon
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
67%
COMPARISON
Comparison
Nov 06, 2026
Stock price -- (CHE: $548.64 vs. UHS: $196.46)
Brand notoriety: CHE and UHS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: CHE: 145% vs. UHS: 244%
Market capitalization -- CHE: $7.17B vs. UHS: $11.58B
CHE [@Hospital/Nursing Management] is valued at $7.17B. UHS’s [@Hospital/Nursing Management] market capitalization is $11.58B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $110.57B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHE’s FA Score shows that 1 FA rating(s) are green while UHS’s FA Score has 0 green FA rating(s).

  • CHE’s FA Score: 1 green, 4 red.
  • UHS’s FA Score: 0 green, 5 red.
According to our system of comparison, CHE is a better buy in the long-term than UHS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHE’s TA Score shows that 6 TA indicator(s) are bullish while UHS’s TA Score has 7 bullish TA indicator(s).

  • CHE’s TA Score: 6 bullish, 4 bearish.
  • UHS’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, UHS is a better buy in the short-term than CHE.

Price Growth

CHE (@Hospital/Nursing Management) experienced а +2.86% price change this week, while UHS (@Hospital/Nursing Management) price change was +14.10% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.14%. For the same industry, the average monthly price growth was +5.08%, and the average quarterly price growth was +15.61%.

Reported Earning Dates

CHE is expected to report earnings on Feb 25, 2027.

UHS is expected to report earnings on Mar 03, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-0.14% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

CHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHE has been loosely correlated with UHS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHE
1D Price
Change %
CHE100%
+2.81%
UHS - CHE
43%
Loosely correlated
+10.91%
PNTG - CHE
33%
Poorly correlated
+6.92%
ENSG - CHE
32%
Poorly correlated
+3.35%
OPCH - CHE
32%
Poorly correlated
-0.38%
NHC - CHE
24%
Poorly correlated
+3.19%
More

UHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, UHS has been loosely correlated with HCA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if UHS jumps, then HCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UHS
1D Price
Change %
UHS100%
+10.91%
HCA - UHS
65%
Loosely correlated
+10.34%
THC - UHS
57%
Loosely correlated
+9.58%
CHE - UHS
43%
Loosely correlated
+2.81%
PNTG - UHS
42%
Loosely correlated
+6.92%
EHC - UHS
36%
Loosely correlated
+4.63%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IEUR76.572.23
+3.00%
iShares Core MSCI Europe ETF (IEUR)
TDVI31.040.24
+0.78%
FT Vest Technology Dividend Target Income ETF (TDVI)
EZJ62.07N/A
N/A
ProShares Ultra MSCI Japan (EZJ)
CCRP18.73N/A
N/A
Columbia Corporate Bond ETF
TZA44.52-2.06
-4.42%
Direxion Daily Small Cap Bear 3X ETF (TZA)